Nuwellis, Inc. (NUWE)
USD 0.96
(-4.0%)
USD 0.96
(-4.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.35 Million USD | -3.25% |
| 2022 | -4.89 Million USD | 12.15% |
| 2021 | -19.05 Million USD | -6.63% |
| 2020 | -16.65 Million USD | 0.07% |
| 2019 | -17.86 Million USD | -6.33% |
| 2018 | -16.8 Million USD | -122.6% |
| 2017 | -10.09 Million USD | 49.55% |
| 2016 | -14.64 Million USD | 41.63% |
| 2015 | -25.63 Million USD | -0.48% |
| 2014 | -25.51 Million USD | -12.45% |
| 2013 | -22.68 Million USD | -54.0% |
| 2012 | -14.69 Million USD | 10.79% |
| 2011 | -16.26 Million USD | -167.69% |
| 2010 | -11.8 Million USD | 7.91% |
| 2009 | -6.38 Million USD | 27.53% |
| 2008 | -6.46 Million USD | 5.04% |
| 2007 | -8.64 Million USD | -80.19% |
| 2006 | -9.73 Million USD | -43.48% |
| 2005 | -5.4 Million USD | -220.03% |
| 2004 | -4.18 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2.24 Million USD | 56.32% |
| 2024 Q1 | -4.74 Million USD | -144.02% |
| 2023 Q4 | -3.48 Million USD | -13.12% |
| 2023 Q3 | -3.08 Million USD | 37.64% |
| 2023 FY | - USD | -3.25% |
| 2023 Q1 | -5.01 Million USD | -12.01% |
| 2023 Q2 | -4.93 Million USD | 1.42% |
| 2022 Q1 | -4.31 Million USD | 0.46% |
| 2022 Q2 | -4.2 Million USD | 2.57% |
| 2022 FY | - USD | 12.15% |
| 2022 Q4 | -4.47 Million USD | -16.94% |
| 2022 Q3 | -3.82 Million USD | 8.93% |
| 2021 Q3 | -5.12 Million USD | -11.49% |
| 2021 FY | - USD | -6.63% |
| 2021 Q2 | -4.59 Million USD | 9.74% |
| 2021 Q1 | -5.09 Million USD | 5.05% |
| 2021 Q4 | -4.33 Million USD | 15.48% |
| 2020 FY | - USD | 0.07% |
| 2020 Q1 | -4.5 Million USD | -2.64% |
| 2020 Q2 | -3.83 Million USD | 14.84% |
| 2020 Q3 | -4.15 Million USD | -8.37% |
| 2020 Q4 | -5.36 Million USD | -29.07% |
| 2019 Q2 | -4.36 Million USD | 6.41% |
| 2019 Q1 | -4.66 Million USD | -9.71% |
| 2019 FY | - USD | -6.33% |
| 2019 Q4 | -4.38 Million USD | 1.39% |
| 2019 Q3 | -4.44 Million USD | -1.85% |
| 2018 Q4 | -4.25 Million USD | -1.48% |
| 2018 Q3 | -4.19 Million USD | -0.29% |
| 2018 Q2 | -4.17 Million USD | 2.81% |
| 2018 Q1 | -4.3 Million USD | -595.39% |
| 2018 FY | - USD | -122.6% |
| 2017 FY | - USD | 49.55% |
| 2017 Q4 | 868 Thousand USD | 130.5% |
| 2017 Q3 | -2.84 Million USD | -25.21% |
| 2017 Q2 | -2.27 Million USD | -8.91% |
| 2017 Q1 | -2.08 Million USD | 26.07% |
| 2016 FY | - USD | 41.63% |
| 2016 Q4 | -2.82 Million USD | 24.82% |
| 2016 Q1 | -4.47 Million USD | 28.66% |
| 2016 Q3 | -3.75 Million USD | 4.01% |
| 2016 Q2 | -3.91 Million USD | 12.54% |
| 2015 FY | - USD | -0.48% |
| 2015 Q2 | -6.26 Million USD | 9.42% |
| 2015 Q3 | -6.19 Million USD | 1.13% |
| 2015 Q4 | -6.27 Million USD | -1.29% |
| 2015 Q1 | -6.91 Million USD | -3.85% |
| 2014 Q3 | -6.04 Million USD | 8.33% |
| 2014 Q2 | -6.58 Million USD | -4.52% |
| 2014 FY | - USD | -12.45% |
| 2014 Q4 | -6.65 Million USD | -10.2% |
| 2014 Q1 | -6.3 Million USD | 9.16% |
| 2013 Q3 | -6.12 Million USD | -16.55% |
| 2013 Q4 | -6.94 Million USD | -13.27% |
| 2013 FY | - USD | -54.0% |
| 2013 Q2 | -5.25 Million USD | -20.52% |
| 2013 Q1 | -4.36 Million USD | -7.17% |
| 2012 Q3 | -3.26 Million USD | 1.87% |
| 2012 Q2 | -3.32 Million USD | 18.43% |
| 2012 Q4 | -4.07 Million USD | -24.77% |
| 2012 FY | - USD | 10.79% |
| 2012 Q1 | -4.07 Million USD | 23.4% |
| 2011 Q4 | -5.32 Million USD | -24.3% |
| 2011 FY | - USD | -167.69% |
| 2011 Q3 | -4.28 Million USD | 0.0% |
| 2010 FY | - USD | 7.91% |
| 2009 FY | - USD | 27.53% |
| 2008 FY | - USD | 5.04% |
| 2007 FY | - USD | -80.19% |
| 2006 FY | - USD | -43.48% |
| 2005 FY | - USD | -220.03% |
| 2004 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -21.272% |
| Cerus Corporation | -26.53 Million USD | 38.363% |
| OrthoPediatrics Corp. | -8.38 Million USD | -95.156% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -55.853% |
| Talis Biomedical Corporation | -66.04 Million USD | 75.235% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 1.913% |
| Inogen, Inc. | -45.67 Million USD | 64.194% |
| Spectral AI, Inc. | -12.26 Million USD | -33.388% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 65.706% |
| CVRx, Inc. | -38.73 Million USD | 57.77% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -363.605% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -35.095% |
| Orthofix Medical Inc. | -86.98 Million USD | 81.197% |
| Venus Concept Inc. | -26.11 Million USD | 37.365% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 67.137% |
| Bioventus Inc. | -23.07 Million USD | 29.103% |
| BrainsWay Ltd. | -2.31 Million USD | -607.746% |
| Envoy Medical, Inc. | -18.23 Million USD | 10.319% |
| electroCore, Inc. | -17.76 Million USD | 7.905% |
| IceCure Medical Ltd | -15.25 Million USD | -7.231% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 67.124% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 2.965% |
| MaxCyte, Inc. | -44.12 Million USD | 62.935% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -39.129% |
| Nexalin Technology, Inc. | -5.69 Million USD | -187.349% |
| PAVmed Inc | -75.74 Million USD | 78.406% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 69.575% |
| RxSight, Inc. | -41.03 Million USD | 60.143% |
| Sight Sciences, Inc. | -49.41 Million USD | 66.901% |
| SI-BONE, Inc. | -34.44 Million USD | 52.517% |
| TELA Bio, Inc. | -40.63 Million USD | 59.747% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 71.944% |
| Treace Medical Concepts, Inc. | -39 Million USD | 58.07% |
| LivaNova PLC | 39.01 Million USD | 141.921% |
| 908 Devices Inc. | -34.02 Million USD | 51.929% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 85.211% |
| Nemaura Medical Inc. | -7.28 Million USD | -124.453% |
| NeuroPace, Inc. | -22.83 Million USD | 28.37% |
| LENSAR, Inc. | -8.71 Million USD | -87.698% |
| Apyx Medical Corporation | -18.11 Million USD | 9.695% |
| Cutera, Inc. | -136.56 Million USD | 88.023% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -383.905% |
| BioSig Technologies, Inc. | -28.15 Million USD | 41.899% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 750.079% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 22.073% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 104.264% |
| Axonics, Inc. | 7.77 Million USD | 310.367% |
| Outset Medical, Inc. | -153.78 Million USD | 89.365% |
| IRIDEX Corporation | -7.44 Million USD | -119.603% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 83.326% |
| IRadimed Corporation | 20.8 Million USD | 178.632% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -102.878% |
| INVO Bioscience, Inc. | -6.88 Million USD | -137.732% |
| Telesis Bio, Inc. | -40.49 Million USD | 59.608% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 144.595% |
| Varex Imaging Corporation | 67.2 Million USD | 124.339% |
| Quipt Home Medical Corp. | 44.07 Million USD | 137.113% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -50.469% |
| Pulmonx Corporation | -55.09 Million USD | 70.311% |
| Dynatronics Corporation | -976 Thousand USD | -1575.806% |
| Modular Medical, Inc. | -17.1 Million USD | 4.368% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -12.917% |
| Semler Scientific, Inc. | 23.58 Million USD | 169.337% |
| InMode Ltd. | 196.28 Million USD | 108.333% |
| Bruker Corporation | 599 Million USD | 102.731% |
| Cytosorbents Corporation | -28.81 Million USD | 43.23% |
| DexCom, Inc. | 916.7 Million USD | 101.784% |
| Align Technology, Inc. | 799.03 Million USD | 102.047% |
| Viveve Medical, Inc. | -20.61 Million USD | 20.667% |
| ZimVie Inc. | 91.07 Million USD | 117.959% |
| Movano Inc. | -29.12 Million USD | 43.842% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -271.053% |
| Nexalin Technology, Inc. | -5.69 Million USD | -187.349% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -363.605% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 91.598% |
| Profound Medical Corp. | -27.12 Million USD | 39.698% |
| Insulet Corporation | 323.6 Million USD | 105.054% |
| enVVeno Medical Corporation | -25.01 Million USD | 34.623% |
| Surmodics, Inc. | 1.18 Million USD | 1476.768% |
| iCAD, Inc. | -6.56 Million USD | -149.139% |
| Biotricity, Inc. | -8.82 Million USD | -85.268% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 83.114% |
| Aethlon Medical, Inc. | -11.84 Million USD | -38.036% |
| InspireMD, Inc. | -20.91 Million USD | 21.783% |
| PAVmed Inc. | -75.74 Million USD | 78.406% |
| BIOLASE, Inc. | -15.13 Million USD | -8.039% |
| Beyond Air, Inc. | -59.03 Million USD | 72.293% |
| FONAR Corporation | 28.25 Million USD | 157.894% |
| AxoGen, Inc. | -13.32 Million USD | -22.719% |
| Vivani Medical, Inc. | -26.6 Million USD | 38.53% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 166.648% |
| Inari Medical, Inc. | 7.11 Million USD | 329.945% |
| UFP Technologies, Inc. | 72.74 Million USD | 122.485% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -383.078% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -165.692% |
| Tenon Medical, Inc. | -15.52 Million USD | -5.332% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -7.14% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 60.565% |
| AdaptHealth Corp. | -171.09 Million USD | 90.44% |
| Sintx Technologies, Inc. | -6.6 Million USD | -147.818% |
| NanoVibronix, Inc. | -3.43 Million USD | -376.157% |
| Quanterix Corporation | -38.08 Million USD | 57.057% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -50.469% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 54620.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 94.101% |
| TransMedics Group, Inc. | -7.6 Million USD | -115.126% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 24.852% |
| NeuroMetrix, Inc. | -7.09 Million USD | -130.502% |
| Hyperfine, Inc. | -47.06 Million USD | 65.245% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 71.948% |
| Biomerica, Inc. | -5.99 Million USD | -172.918% |
| Bone Biologics Corporation | 479.57 Thousand USD | 3510.541% |
| AVITA Medical, Inc. | -39.56 Million USD | 58.663% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -78.307% |
| Silk Road Medical, Inc | -45.08 Million USD | 63.718% |